A detailed history of Verition Fund Management LLC transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Verition Fund Management LLC holds 133,025 shares of ALXO stock, worth $160,960. This represents 0.0% of its overall portfolio holdings.

Number of Shares
133,025
Previous 32,571 308.42%
Holding current value
$160,960
Previous $196,000 23.47%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.81 - $8.13 $181,821 - $816,691
100,454 Added 308.42%
133,025 $242,000
Q2 2024

Aug 14, 2024

BUY
$5.84 - $17.56 $190,214 - $571,946
32,571 New
32,571 $196,000
Q3 2023

Nov 14, 2023

BUY
$4.19 - $7.35 $48,809 - $85,620
11,649 New
11,649 $55,000

Others Institutions Holding ALXO

About ALX ONCOLOGY HOLDINGS INC


  • Ticker ALXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,747,100
  • Market Cap $49.3M
  • Description
  • ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...
More about ALXO
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.